Abstract

Respiratory diseases are a widespread group of pathological processes that affect people of different ages. Inflammatory changes of various etiologies on the surface of the respiratory epithelium are accompanied by a violation of mucociliary clearance, and therefore the rate of evacuation of the secret decreases, its production increases, and the rheological properties of the mucin change. Significant accumulation of thick mucus is a clinical feature of many respiratory diseases, including acute rhinosinusitis. Appointment to patients with pathology of the respiratory system of drugs that affect the evacuation, properties and production of mucus, is pathogenetically justified. Phytopreparations GeloMirtol® and GeloMirtol® forte are effective in treating patients with rhinosinusitis of various ages, including children from 6 and 10, respectively. The active component of these drugs - Myrtle standardized - distillate eucalyptus oil (main ingredient - 66% of the total), myrtle, sweet orange and lemon, has a complex mechanism of action, has an expectorant, anti-inflammatory, bacteriostatic effect, helps clean the respiratory tract and restore normal mucous function shell. GeloMirtol® and GeloMirtol® forte simultaneously affect several parts of the development of the pathological process, increasing the results of complex treatment of respiratory diseases.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.